Condition
Raynaud Phenomena clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Raynaud Phenomena clinical trials that are recruiting, at sites in 2 countries (most in United States (1), Poland (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Polish registry of heart nerve–targeting treatments (cardioneuroablation and cardioneuromodulation)
This registry collects information to see how nerve-targeting heart procedures work for adults with fainting, abnormal heart rhythms, or orthostatic problems.
-
Open-label oral treprostinil for Raynaud's
This trial will test whether oral sustained-release treprostinil (UT-15C) can reduce the number and severity of Raynaud's attacks in adults with frequent primary or secondary Raynaud's.
Related topics
Quick answers
How many Raynaud Phenomena clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.